38 results
F-3
EX-5.1
AUTL
Autolus Therapeutics plc
3 May 22
Shelf registration (foreign)
7:25pm
to the Relevant Agreements will at all relevant times remain, in compliance with all applicable anti-corruption, anti-money laundering, anti-terrorism
S-3ASR
EX-5.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
is, and the Company and each party to the Relevant Agreements will at all relevant times remain, in compliance with all applicable anti-corruption, anti
F-3
EX-5.1
AUTL
Autolus Therapeutics plc
14 Apr 22
Shelf registration (foreign)
9:30pm
to the Relevant Agreements will at all relevant times remain, in compliance with all applicable anti-corruption, anti-money laundering, anti-terrorism
8-K
EX-5.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
of the Agreements is and will at all relevant times remain, in compliance with all applicable anti-corruption, anti-money laundering, anti-terrorism
6-K
EX-5.1
wr71t2tlhu
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-5.1
fa6csb6v8t9bhrszdux
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
6-K
EX-5.1
3gv0y6 lyjny2xu7png
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
F-3
EX-5.1
d0fkhbaaap05 t2gh
6 Aug 21
Shelf registration (foreign)
2:30pm
S-3ASR
EX-5.1
tgoya
7 Feb 24
Automatic shelf registration
10:00pm
6-K
EX-5.1
tw720sn
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1
0lg lqjrk
15 Mar 19
Annual Report and Accounts
5:26pm
6-K
EX-1
v8crf3nkv5q0v5wr1k5
30 Jun 21
Annual Report and Accounts
6:05am
10-K
wf1ggtn
21 Mar 24
Annual report
4:55pm
6-K
EX-1
kdvbt2hi4zzya6h7
26 May 20
Current report (foreign)
4:31pm
F-1/A
2dllxaizz sxfjvn
8 Jun 18
Registration statement (foreign) (amended)
6:25am
20-F
abli447s0ttxmsor
23 Nov 18
Annual report (foreign)
12:00am
F-1
86ij89mz8x17c934bfdu
7 May 18
Registration statement (foreign)
4:45pm